Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland

Siteman Cancer Center- Washington University School of Medicine in St. Louis, St Louis, Missouri

Comprehensive Cancer Center at Wake Forest University (CCCWFU), Winston-Salem, North Carolina